FindTrial
Sign In

A Study to create an artificial intelligence based risk assessment model to detect deterioration of patients clinical status

Artificial Intelligence Based Risk Assessment of Patients Clinical Respiratory Progression Status

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027595
Enrollment
500
Registered
2020-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Wipro GE Healthcare Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted with suspected COVID-19 at AIIMS Rishikesh (irrespective of COVID Status) during the study period who are able and willing to give informed written consent (Signature/Thumb impression)

Exclusion criteria

Exclusion criteria: Unable or unwilling to give informed consent

Design outcomes

Primary

MeasureTime frame
Proof of concept Artificial Intelligence based Risk assessment modelTimepoint: 8 weeks—

Secondary

MeasureTime frame
Testing of iterated model in the clinical setting on prospectively collected datasetsTimepoint: 16 weeks—

Countries

India

Contacts

Public ContactDebendra Kumar Tripathy

All India Institute of Medical Sciences Rishikesh

drdebendra@gmail.com9443278806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026